How many insider trades does FilingIQ track for APMD?

FilingIQ tracks 25 Form 4 insider transactions for APMD (Apnimed, Inc.), covering filings from Aug 3, 2026 onwards. 25 of those are dated within the last 90 days.

Are APMD insiders net buyers or net sellers?

Across the full Form 4 history for APMD, 2 transactions (8%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does APMD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is APMD in?

Apnimed, Inc. (APMD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $949.99M.

APMD insider trading

NasdaqGS Healthcare

Apnimed, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

8% / 0%

Market cap

$949.99M

About Apnimed, Inc.

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Company website: apnimed.com

APMD insider activity at a glance

FilingIQ tracks 25 insider transactions for APMD in filings since Aug 3, 2026. The most recent transaction is dated Aug 3, 2026.

Across the full history, 2 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on APMD insider trades is 56.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live APMD trades on FilingIQ Raw filings on SEC EDGAR

Latest APMD Form 4 filings

Alpha Wave Ventures GP, Ltd

C Aug 5, 2026

Morningside Venture Investments Ltd

PCJ Aug 5, 2026

Kelly Michael B Chief Financial Officer

Lind Kevin Robert Chief Executive Officer

Molnar Dennis Patrick President

AD Aug 3, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 779

UNITED THERAPEUTICS Corp

Kymera Therapeutics, Inc.

TMO 130

THERMO FISHER SCIENTIFIC INC.

ONC 126

BeOne Medicines Ltd.

ATTO 123

Attovia Therapeutics, Inc.

Frequently asked

How many insider trades does FilingIQ track for APMD?: FilingIQ tracks 25 Form 4 insider transactions for APMD (Apnimed, Inc.), covering filings from Aug 3, 2026 onwards. 25 of those are dated within the last 90 days.
Are APMD insiders net buyers or net sellers?: Across the full Form 4 history for APMD, 2 transactions (8%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does APMD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is APMD in?: Apnimed, Inc. (APMD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $949.99M.

Methodology & sources

Every APMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.